Literature DB >> 31301935

Advanced hilar cholangiocarcinoma: An aggressive surgical approach for the treatment of advanced hilar cholangiocarcinoma: Perioperative management, extended procedures, and multidisciplinary approaches.

Takashi Mizuno1, Tomoki Ebata2, Masato Nagino2.   

Abstract

Hilar cholangiocarcinoma is a highly intractable malignancy. One of the reasons for its intractability is that most patients with the disease are diagnosed with an advanced stage of the disease at their initial presentation. Surgical resection is the standard therapy for hilar cholangiocarcinoma, providing a chance for a cure, and an aggressive surgical approach substantially increases the number of resectable tumors that are initially regarded as unresectable tumors. The success and standardization of the aggressive approach is warranted by meticulous preoperative management that prevents fatal postoperative complications. Extended resection procedures, including hepatic trisectionectomy for Bismuth type IV tumors, hepatopancreaticoduodenectomy for tumors with extensive longitudinal tumor spreading, and combined vascular resection with reconstruction for tumors with the involvement of hepatic vascular structures, have been challenged to expand the surgical indication. Due to acceptable surgical/survival outcomes, the three extended procedures are currently regarded as extended but standard options in specialized hepatobiliary centers. Although it remains a controversial multidisciplinary approach, the combination of these extended procedures with an adjuvant/neoadjuvant treatment is a promising approach for further improving the resectability of tumors and the survival of patients.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Hepatopancreaticoduodenectomy; Perihilar cholangiocarcinoma; Vascular reconstruction

Mesh:

Year:  2019        PMID: 31301935     DOI: 10.1016/j.suronc.2019.07.002

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  11 in total

1.  Validation study of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma.

Authors:  Takehiro Noji; Satoko Uemura; Jimme K Wiggers; Kimitaka Tanaka; Yoshitsugu Nakanishi; Toshimichi Asano; Toru Nakamura; Takahiro Tsuchikawa; Keisuke Okamura; Pim B Olthof; William R Jarnagin; Thomas M van Gulik; Satoshi Hirano
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

2.  Risk factors of delayed recovery from general anesthesia in patients undergoing radical biliary surgery: What can we prevent.

Authors:  Guohui Zhang; Bingbing Pan; Dan Tan; Yingzi Ling
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

3.  Liver Resection for Type IV Perihilar Cholangiocarcinoma: Left or Right Trisectionectomy?

Authors:  Heithem Jeddou; Stylianos Tzedakis; Francesco Orlando; Antoine Robert; Eric Meneyrol; Damien Bergeat; Fabien Robin; Laurent Sulpice; Karim Boudjema
Journal:  Cancers (Basel)       Date:  2022-06-04       Impact factor: 6.575

Review 4.  Radiomics of Biliary Tumors: A Systematic Review of Current Evidence.

Authors:  Francesco Fiz; Visala S Jayakody Arachchige; Matteo Gionso; Ilaria Pecorella; Apoorva Selvam; Dakota Russell Wheeler; Martina Sollini; Luca Viganò
Journal:  Diagnostics (Basel)       Date:  2022-03-28

Review 5.  Concomitant Hepatic Artery Resection for Advanced Perihilar Cholangiocarcinoma: A Narrative Review.

Authors:  Takehiro Noji; Satoshi Hirano; Kimitaka Tanaka; Aya Matsui; Yoshitsugu Nakanishi; Toshimichi Asano; Toru Nakamura; Takahiro Tsuchikawa
Journal:  Cancers (Basel)       Date:  2022-05-27       Impact factor: 6.575

6.  Surgical outcomes of perihilar cholangiocarcinoma based on the learning curve of a single surgeon at a tertiary academic hospital: A retrospective study.

Authors:  Hye Jeong Park; Dai Hoon Han; Gi Hong Choi; Jin Sub Choi
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2021-02-28

7.  Complete laparoscopic radical resection of hilar cholangiocarcinoma: technical aspects and long-term results from a single center.

Authors:  Jingdong Li; Yongfu Xiong; Gang Yang; Lixing Zhang; Muhammad Riaz; Jian Xu; Qiang Li; Zhaohui Tang
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2020-07-16       Impact factor: 1.195

8.  Chronological analysis of surgical and oncological outcomes after the treatment of perihilar cholangiocarcinoma.

Authors:  Sung Ho Lee; Gi Hong Choi; Dai Hoon Han; Kyung Sik Kim; Jin Sub Choi; Seoung Yoon Rho
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2021-02-28

Review 9.  Moving forward in the treatment of cholangiocarcinoma.

Authors:  Tommaso M Manzia; Alessandro Parente; Ilaria Lenci; Bruno Sensi; Martina Milana; Carlo Gazia; Alessandro Signorello; Roberta Angelico; Giuseppe Grassi; Giuseppe Tisone; Leonardo Baiocchi
Journal:  World J Gastrointest Oncol       Date:  2021-12-15

Review 10.  Liver transplantation for intrahepatic and hilar cholangiocellular carcinoma: Most recent updates in the literature.

Authors:  Susumu Eguchi; Masaaki Hidaka; Takanobu Hara; Hajime Matsushima; Akihiko Soyama
Journal:  Ann Gastroenterol Surg       Date:  2022-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.